Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $66.45 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $20.13 | 1 | $0 (2021) |
| Ultragenyx Pharmaceutical Inc. | $19.10 | 1 | $0 (2021) |
| Novo Nordisk Inc | $13.77 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $13.45 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.77 | 1 | Novo Nordisk Inc ($13.77) |
| 2021 | $52.68 | 3 | Janssen Pharmaceuticals, Inc ($20.13) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Diabetes | ||||||
| 06/23/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2021 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $19.10 | General |
| 06/16/2021 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 234 | 279 | $91,528 | $19,178 |
| 2022 | 3 | 135 | 142 | $43,158 | $10,646 |
| 2021 | 1 | 13 | 14 | $280.00 | $48.72 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 153 | $46,020 | $9,859 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 99 | $41,662 | $8,660 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $2,890 | $630.33 | 21.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 13 | $956.00 | $28.60 | 3.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 84 | $24,570 | $6,241 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 34 | $13,828 | $2,979 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $4,760 | $1,426 | 30.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 13 | 14 | $280.00 | $48.72 | 17.4% |
About Danyelle Frantz, NP-C
Danyelle Frantz, NP-C is a Family healthcare provider based in Mount Pocono, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/19/2020. The National Provider Identifier (NPI) number assigned to this provider is 1497358618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Danyelle Frantz, NP-C has received a total of $66.45 in payments from pharmaceutical and medical device companies, with $13.77 received in 2022. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($66.45).
As a Medicare-enrolled provider, Frantz has provided services to 382 Medicare beneficiaries, totaling 435 services with total Medicare billing of $29,872. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Mount Pocono, PA
- Active Since 11/19/2020
- Last Updated 04/07/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1497358618
Products in Payments
- INVOKANA (Drug) $20.13
- Rybelsus (Drug) $13.77
- FARXIGA (Drug) $13.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.